Aaron Sato
Chief Tech/Sci/R&D Officer bei TWIST BIOSCIENCE CORPORATION
Profil
Zurzeit ist Aaron K. Sato Chief Scientific Officer bei Twist Bioscience Corp. In seiner früheren Laufbahn war er Vice President-Research bei Sutro Biopharma, Inc, Chief Scientific Officer von LakePharma, Inc, Vice President-Protein Sciences bei Surrozen, Inc, Director-Antibody Engineering bei OncoMed Pharmaceuticals, Inc. und Senior Director-Discovery bei Dyax Corp. Aaron K. Sato promovierte am Massachusetts Institute of Technology und erhielt einen Bachelor-Abschluss von der University of Puget Sound.
Aktive Positionen von Aaron Sato
| Unternehmen | Position | Beginn |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Aaron Sato
| Unternehmen | Position | Ende |
|---|---|---|
LakePharma, Inc.
 LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Chief Tech/Sci/R&D Officer | 01.06.2018 |
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01.01.2017 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2017 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | 01.07.2012 |
| DYAX CORP. | Corporate Officer/Principal | 01.07.2006 |
Ausbildung von Aaron Sato
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Puget Sound | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
LakePharma, Inc.
LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
